MYRIAD GENETICS INCMYGN
ASignal's systematic analysis rates MYGN as Bullish.
Reflects the latest available analysis · analyzed Oct 10, 2026
The case on MYGN
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- Positive MACD momentum with MACD above signal line
- Gross margin of 68.83% indicates strong pricing power
- Current ratio of 2.21x suggests solid short-term financial health
- Free cash flow positive at $18.19M
- Negative operating and net margins (-20.40%, -13.96%)
- Negative return on equity (-32.54%) and return on assets (-8.60%)
- Revenue growth declining YoY at -10.50%
- Forward P/E of -7.31x and negative EV/EBITDA suggest valuation challenges
- Low news coverage with only 3 sources and limited Reddit activity
See the full verdict on MYGN
ASignal Rank (1-4), confidence score, Buffett / Ackman / Dalio grades, price targets, and the full reasoning behind the call.
How ASignal analyzes MYGN
Most investors never get a second opinion, let alone several. ASignal runs MYGN past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: Warren Buffett's value discipline, Bill Ackman's activist lens, and Ray Dalio's macro view. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.